IBD Patients: Don't Skip That Second COVID Shot

(MedPage Today) -- In patients with inflammatory bowel disease (IBD), treatment with infliximab (Remicade) was associated with attenuated immunogenicity to a single dose of either the Pfizer or AstraZeneca COVID-19 vaccine, a large British cohort...